Disrupting the Status Quo in Clinical Trials

How payers, patients, and data are shaping the future of clinical trials

September 27, 2017
New York, NY

Hosted by: New York City Health Business Leaders & PulsePoint

Clinical trials are changing—and changing rapidly. From greater patient involvement, integration of cost-effectiveness considerations in trial design, increasing pressure to make drug available faster, and inclusion of new sources of data, there are new opportunities to collect, curate, and integrate more data and new sensibilities. But, these new opportunities also represent new challenges for supporting clinical trials in general—integrity of new data, relevance of new sources, applicability, noise versus signal, and the overall challenges of managing a greater variety of data in a complex environment.